We are live on ! Find out more
AIC

AWM Investment Company Portfolio holdings

AUM $903M
1-Year Est. Return 163.47%
This Fund
S&P 500
This Quarter Est. Return
+38.03%
1 Year Est. Return
+163.47%
3 Year Est. Return
+487.55%
5 Year Est. Return
+638.08%
10 Year Est. Return
+8,997.75%
AUM
$1.07B
AUM Growth
+$175M
Cap. Flow
-$43.5M
Cap. Flow %
-4.08%
Top 10 Hldgs %
35.14%
Holding
116
New
22
Increased
19
Reduced
23
Closed
14

Top Sells

Rank Stock Value
1
AMSC icon
American Superconductor
AMSC
+$40.6M
2
ONDS icon
Ondas Inc
ONDS
+$11.1M
3
ASPI icon
ASP Isotopes
ASPI
+$8.97M
4
ARGX icon
argenx
ARGX
+$7.42M
5
RCAT icon
Red Cat Holdings
RCAT
+$7.02M

Sector Composition

Rank Sector Weight
1 Technology 35.94%
2 Healthcare 25.81%
3 Industrials 14.65%
4 Consumer Discretionary 7.49%
5 Materials 3.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFU icon
51
InfuSystem Holdings
INFU
$241M
$5.82M 0.55%
561,656
-710,640
-56% -$5.9M
GRWG icon
52
GrowGeneration
GRWG
$111M
$5.81M 0.55%
3,109,535
TLSI icon
53
TriSalus Life Sciences
TLSI
$356M
$5.81M 0.54%
1,250,000
CNTY icon
54
Century Casinos
CNTY
$34.3M
$5.73M 0.54%
2,195,549
LMAT icon
55
LeMaitre Vascular
LMAT
$1.86B
$5.43M 0.51%
62,000
-68,000
-52% -$6.07M
ALLT icon
56
Allot
ALLT
$378M
$5.28M 0.49%
+498,700
New +$4.23M
AVDL
57
DELISTED
Avadel Pharmaceuticals
AVDL
$4.83M 0.45%
316,189
PEPG icon
58
PepGen
PEPG
$201M
$4.74M 0.44%
+1,025,000
New +$1.65M
OPRX icon
59
OptimizeRx
OPRX
$134M
$4.72M 0.44%
230,421
-25,000
-10% -$397K
PVLA
60
Palvella Therapeutics
PVLA
$2.23B
$4.35M 0.41%
69,416
AIRO
61
AIRO Group Holdings
AIRO
$267M
$4.32M 0.41%
+225,000
New +$4.93M
XTNT icon
62
Xtant Medical Holdings
XTNT
$43.2M
$4.28M 0.4%
6,594,121
-2,500
-0% -$1.58K
CRNX icon
63
Crinetics Pharmaceuticals
CRNX
$8.97B
$4.17M 0.39%
100,000
+5,000
+5% +$160K
VELO
64
Velo3D Inc
VELO
$454M
$4.09M 0.38%
+1,333,333
New +$4.61M
ABX
65
Abacus Global Management
ABX
$850M
$4.07M 0.38%
710,683
-373,012
-34% -$2.22M
LSF icon
66
Laird Superfood
LSF
$48.2M
$4.07M 0.38%
729,506
+130,095
+22% +$818K
FBRX icon
67
Forte Biosciences
FBRX
$1.57B
$3.93M 0.37%
+261,821
New +$3.02M
PGNY icon
68
Progyny
PGNY
$1.96B
$3.87M 0.36%
180,000
UCTT
69
Ultra Clean Holdings
UCTT
$4.16B
$3.83M 0.36%
140,440
SPIR icon
70
Spire Global
SPIR
$574M
$3.66M 0.34%
332,795
+66,250
+25% +$684K
APEI icon
71
American Public Education
APEI
$834M
$3.65M 0.34%
92,500
-6,500
-7% -$206K
HIPO icon
72
Hippo Holdings
HIPO
$867M
$3.62M 0.34%
+100,000
New +$3.11M
FRGE
73
DELISTED
Forge Global Holdings
FRGE
$3.49M 0.33%
206,392
OPK icon
74
Opko Health
OPK
$1.04B
$3.41M 0.32%
2,200,000
+200,000
+10% +$275K
IPWR icon
75
Ideal Power
IPWR
$69.5M
$3.25M 0.3%
645,745
+44,214
+7% +$228K

Similar funds

AWM Investment Company's Q3 2025 Portfolio in Review

As of Q3 2025, AWM Investment Company held 116 positions worth $1.07B, up 20% from $892M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AWM Investment Company withdrew a net $43.5M in Q3 2025, closing 14 positions and reducing 23 holdings. Its most notable exit was Ondas Inc, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AWM Investment Company opened a new position in Galaxy Digital Inc worth $15.6M.

  • AWM Investment Company's largest Q3 2025 buy was Galaxy Digital Inc: 460,000 shares worth $15.6M.
  • AWM Investment Company added most to Kopin in Q3 2025, an estimated $7.37M increase.
  • AWM Investment Company's biggest Q3 2025 reduction was American Superconductor, cutting an estimated $40.6M.
  • AWM Investment Company fully exited Ondas Inc in Q3 2025, selling an estimated $11.1M.
  • AWM Investment Company's ten largest holdings make up 35% of its $1.07B portfolio in Q3 2025.
  • AWM Investment Company opened 22 new positions and closed 14 in Q3 2025.
  • AWM Investment Company's portfolio value rose 20% quarter-over-quarter to $1.07B.

Based on AWM Investment Company's 13F filing for Q3 2025, filed 13 Nov 2025.